Authors: Tobin, SW Brown, MK Douville, K Payne, DC Eastman, A Arrick, BA

Citation: Sw. Tobin et al., Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: A role for Bcl-2, CELL GROWTH, 12(2), 2001, pp. 109-117

Authors: Lu, ML Arrick, BA

Citation: Ml. Lu et Ba. Arrick, Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms, ONCOGENE, 19(54), 2000, pp. 6351-6360

Authors: Brown, DL Cole, BF Arrick, BA

Citation: Dl. Brown et al., More about: Multifactorial analysis of differences between sporadic breastcancers and cancers involving BRCA1 and BRCA2 mutations - Response, J NAT CANC, 91(16), 1999, pp. 1422-1422

Authors: Brown, DL Cole, BF Arrick, BA

Citation: Dl. Brown et al., Multifactorial analysis of differences between sporadic breast cancers andcancers involving BRCA1 and BRCA2 mutations, J NAT CANC, 91(1), 1999, pp. 90-91

Authors: Archey, WB Sweet, MP Alig, GC Arrick, BA

Citation: Wb. Archey et al., Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-beta 3, CANCER RES, 59(10), 1999, pp. 2292-2296